Focus Partners Wealth’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$293K Buy
+3,009
New +$282K ﹤0.01% 2346

Other funds holding PBE

Focus Partners Wealth's PBE Position: Q3 2026 in Review

Focus Partners Wealth opened a new position in Invesco Biotechnology & Genome ETF (PBE) in Q3 2026: 3,009 shares worth $293K. The stake represents ﹤0.01% of the portfolio and ranks #2346 among its holdings.

122 funds tracked by Wall St. Rank hold PBE as of Q3 2026.

  • Focus Partners Wealth held 3,009 shares of Invesco Biotechnology & Genome ETF worth $293K as of Q3 2026.
  • Invesco Biotechnology & Genome ETF was a new Focus Partners Wealth position in Q3 2026.
  • Invesco Biotechnology & Genome ETF made up ﹤0.01% of Focus Partners Wealth's portfolio in Q3 2026, its #2346 holding.
  • 122 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q3 2026.

Based on Focus Partners Wealth's 13F filing for Q3 2026, filed 12 Nov 2026.